AAMS.pdf

Embed Size (px)

Citation preview

  • 8/12/2019 AAMS.pdf

    1/3

    American Journal of Public Health | October 2002, Vol 92, No. 101604 | Research and Practice | Peer Reviewed | Lewith et al.

    RESEARCH AND PRACTICE

    CONCLUSIONS

    Where does all of this leave us when at-

    tempting a riskbenefit analysis? On one side

    we have uncertain benefits; on the other we

    must consider common nonserious adverse

    effects as well as serious complications that

    occur at an unknown rate. Given this situa-

    tion, a tentative riskbenefit analysis cannot

    produce a positive result. The conclusion

    must therefore be that, according to the evi-

    dence to date, chiropractic spinal manipula-

    tion does not demonstrably do more good

    than harm. In view of the incompleteness of

    our current knowledge and the popularity of

    chiropractic, research into this complex area

    should be intensified.

    About the AuthorThe author i s with the Department of Complementary

    Medicine, School of Sport and Health Sciences, Uni versity

    of Exeter, England.

    Requests for reprin ts should be sent to E. Ernst, MD,

    PhD, FRCP, Depar tment of Complementar y Medicine,

    School of Sport and Health Sciences, Uni versity of Exeter,

    25 Vi ctoria Park Rd, Exeter EX2 4NT, England (e-mail:

    [email protected]).

    This brief was accepted May 27 , 20 02.

    Human Participant ProtectionNo protocol approval was needed for this study.

    References1. Coulter ID, Hurwitz EL, Adams AH, Genovese BJ,

    Hays R, Shekelle PG. Patients using chiropractors in

    North America. Spine. 2002;27:291298.

    2. Ernst E. Prevalence of use of complementary/

    alternative medicine: a systematic review. Bull World

    Health Organ. 2000;78:252257.

    3. Shekelle PG, Adams AH, Chassin MR, Hurwitz

    EL, Brook RH. Spinal manipulation for low back pain.

    Ann I ntern M ed. 1992;117:590598.

    4. Meeker WC, Haldeman S. Chiropractic: a profes-

    sion at the crossroads of mainstream and alternative

    medicine. Ann I ntern M ed. 2002;136:216227.

    5. Assendelft WJJ, Koes BW, van der Heijden GJMG,

    Bouter LM. The effectiveness of chiropractic for treat-

    ment of low back pain: an update and attempt at statis-tical pooling. J Mani pulati ve Physiol Ther. 1996;19:

    499507.

    6. Skargren EI, Oberg BE, Carlsson PG, Gade M.

    Cost and effectiveness analysis of chiropractic and

    physiotherapy treatment for low back and neck pain

    six-month follow-up. Spine. 1997;22:21672177.

    7. Cherkin DC, Deyo RA, Battie M, Street J, Barlow

    W. An important trial of chiropractic for acute low

    back pain. N Engl J Med. 1998;339:10211029.

    8. Giles LGF, Mller R. Chronic spinal pain syn-

    dromes: a clinical pilot trial comparing acupuncture, a

    nonsteroidal anti-inflammatory drug, and spinal manip-

    ulation. J Man ipulative Physiol Ther. 1999;22:376381.

    9. Bronfort G, Evans RL, Anderson AV, et al. Non-

    operative treatments for sciatica: a pilot study for a

    randomized clinical trial. J Man ipulative Physiol Ther.

    2000;23:536544.

    10. Ernst E, Harkness EF. Spinal manipulation: a sys-

    tematic review of sham-controlled, double-blind, ran-

    domized clinical trials. J Pain Symptom Manage. 2001;

    24:879889.

    11. Ernst E. Prospective investigations into the safety

    of spinal manipulation. J Pain Symptom Manage. 2001;

    21:238242.

    12. Rothwell DM, Bondy SJ, Wil liams SJ. Chiroprac-

    tic manipulation and stroke: a population-based case-

    control study. Stroke. 2001;32:10541060.

    13. Haldeman S, Kohlbeck FJ, McGregor M. Unpre-

    dictability of cerebrovascular ischemia associated with

    cervical spine manipulation. Spine. 2002;27:4955.

    14. Stevinson C, Honan W, Cooke B, Ernst E. Neuro-

    logical complications of cervical spine manipulation. J R

    Soc Med. 2001;94:107110.

    Do Attitudes Towardand Beliefs AboutComplementaryMedicine Affect

    Treatment Outcomes?| George T. Lewith, MA, DM, FRCP, MRCGP,

    Michael E. Hyland, PhD, BSc, and StephenShaw, PhD, MSc

    Many patients seek help from practitioners of

    complementary and alternative medicine

    (CAM). Patients prior knowledge of CAM and

    desire for egalitarian relationships with med-

    ical practitioners have been shown to increase

    CAM use,1,2 as have higher scores on the Ab-

    sorption scale (a measure of anxiety and self-

    absorption).3 Other personality scales do not

    predict CAM use.4

    Although users of CAM might not agree, a

    common view among scientists is that CAM

    outcomes are mediated through a placebo ef-

    fect5,6; that is, patients improve because they

    expect to do so. Our aims in the study de-

    scribed here were to assess the validity of the

    Attitudes toward Alternative Medicine Scale

    (AAMS) and to determine whether asthmatic

    patients who had positive attitudes toward

    and beliefs about CAM showed greater posi-

    tive changes in outcomes.

    METHODS

    During 1996 through 1998, we conducted

    a randomized, double-blind, placebo-

    controlled trial among 327 patients allergic to

    house dust mites. The study, which took place

    in the counties of Hampshire and Dorset in

    England, was designed to evaluate the effects

    of a homeopathic dilution of this allergen.7

    Patients completed the AAMS and the Posi-

    tive and Negative Affect Scales (PANAS) on 2

    occasions: 4 weeks before and 16 weeks after

    study randomization. Higher scores on the

    AAMS indicate more positive attitudes to-ward CAM.8,9 Higher scores on the 2 sub-

    scales of the PANAS indicate higher levels of

    the variable assessed (i.e., positive or negative

    affect).10

    Spirometry and a measure of quality of

    life (the Asthma Bother Profile [ABP]11) were

    completed at baseline and at 6, 12, and 16

    weeks. Patient diaries were completed on al-

    ternate weeks throughout the 20-week

    study; these diaries included information on

    diurnal peak expiratory flow, among other

    outcomes.7 Spirometry, peak expiratory flow,

    and ABP scores were the primary outcomesassessed.

    The AAMS has received only limited vali-

    dation, so we carried out a factor analysis.

    Correlationsof baseline AAMS scores with all

    other baseline values were computed to de-

    termine whether personality factorsor asthma

    severity determined attitudes toward CAM. To

    test whether beliefsor other baseline factors

    predicted outcomes, we calculated spirometry,

    ABP, and peak expiratory flow change scores

    (final scoresminusbaseline scores).Three

    multiple regression analyseswere conducted

    with each of the 3 change variables in turn as

    the dependent variable; all baseline variables

    were considered independent.

    Pearson correlations for the 2 AAMS

    scores (prerandomization and postrandomiza-

    tion) were calculated to examine AAMS score

    changes. Changes in AAMS scores were cor-

    related with changes in peak expiratory flow,

    spirometry, and ABP scores. An analysis of

    variance compared baseline and posttreat-

  • 8/12/2019 AAMS.pdf

    2/3

  • 8/12/2019 AAMS.pdf

    3/3

    American Journal of Public Health | October 2002, Vol 92, No. 101606 | Research and Practice | Peer Reviewed | Lee et al.

    RESEARCH AND PRACTICE

    TABLE 2Pearson ProductMoment Correlations Between Changes in Outcome Variables

    and Baseline Measures

    Change in

    Baseline Change Change in Change in Change in Asthma

    Measure FEV 1 Predicted FEV1 PEF: AM PEF: PM Bother Score

    FEV1 0.259** 0.189** 0.147* 0.023 0.038

    Predicted FEV1 0.334** 0.352** 0.069 0.006 0.046

    PEF: AM 0.030 0.077 0.202** 0.089 0.028

    PEF: PM 0.031 0.081 0.097 0.145* 0.055

    Positive affect 0.010 0.012 0.020 0.003 0.078

    Negative affect 0.046 0.072 0.100 0.130 0.193**

    Asthma bother score 0.072 0.031 0.078 0.080 0.353**

    AAMS score 0.120 0.141 0.102 0.024 0.023

    Spirometry score 0.063 0.025 0.075 0.067 0.011

    Mood 0.014 0.034 0.000 0.057 0.094

    Symptoms 0.125 0.074 0.060 0.052 0.068

    Problem-free days 0.176* 0.131 0.046 0.031 0.065

    Note. FEV1 =forced expiratory volume in 1 second; PEF=peak expiratory flow; AAMS=Attitudes to Alternative Medicine Scale.*P< .05; **P